These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 14526458)

  • 1. [Problems with drug stability. Galenic formulation of recombinant drugs].
    Zimmer A
    Pharm Unserer Zeit; 2003; 32(5):384-9. PubMed ID: 14526458
    [No Abstract]   [Full Text] [Related]  

  • 2. Recent trends in stabilising peptides and proteins in pharmaceutical formulation - considerations in the choice of excipients.
    Jorgensen L; Hostrup S; Moeller EH; Grohganz H
    Expert Opin Drug Deliv; 2009 Nov; 6(11):1219-30. PubMed ID: 19678792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-throughput assessment of antigen conformational stability by ultraviolet absorption spectroscopy and its application to excipient screening.
    Dasnoy S; Le Bras V; Préat V; Lemoine D
    Biotechnol Bioeng; 2012 Feb; 109(2):502-16. PubMed ID: 21928339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of N-terminal glutamate cyclization of recombinant monoclonal antibody in formulation development.
    Yu L; Vizel A; Huff MB; Young M; Remmele RL; He B
    J Pharm Biomed Anal; 2006 Oct; 42(4):455-63. PubMed ID: 16828250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of Ala 125 recombinant human interleukin-2 in solution.
    Reyes N; Ruiz L; Aroche K; Gerónimo H; Brito O; Hardy E
    J Pharm Pharmacol; 2005 Jan; 57(1):31-7. PubMed ID: 15638990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein drug stability: a formulation challenge.
    Frokjaer S; Otzen DE
    Nat Rev Drug Discov; 2005 Apr; 4(4):298-306. PubMed ID: 15803194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles.
    Kumar PS; Ramakrishna S; Saini TR; Diwan PV
    Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of the SeDeM Diagram and a new mathematical equation in the design of direct compression tablet formulation.
    Suñé-Negre JM; Pérez-Lozano P; Miñarro M; Roig M; Fuster R; Hernández C; Ruhí R; García-Montoya E; Ticó JR
    Eur J Pharm Biopharm; 2008 Aug; 69(3):1029-39. PubMed ID: 18367387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of a screening method to determine excipients which optimize the extent and stability of supersaturated drug solutions and application of this system to solid formulation design.
    Vandecruys R; Peeters J; Verreck G; Brewster ME
    Int J Pharm; 2007 Sep; 342(1-2):168-75. PubMed ID: 17573214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific interactions between diphenhydramine and alpha-helical poly(glutamic acid)--a new ion-pairing complex for taste masking and pH-controlled diphenhydramine release.
    Agresti C; Tu Z; Ng C; Yang Y; Liang JF
    Eur J Pharm Biopharm; 2008 Sep; 70(1):226-33. PubMed ID: 18514496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and aerodynamic evaluation of spray dried recombinant human growth hormone using protein stabilizing agents.
    Jalalipour M; Gilani K; Tajerzadeh H; Najafabadi AR; Barghi M
    Int J Pharm; 2008 Mar; 352(1-2):209-16. PubMed ID: 18164150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclodextrins in drug delivery.
    Loftsson T; Jarho P; Másson M; Järvinen T
    Expert Opin Drug Deliv; 2005 Mar; 2(2):335-51. PubMed ID: 16296758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of xylitol on the stability and morphological parameters of tablets with sorbitol made by direct tabletting of formulation components.
    Zgoda MM; Woskowicz M; Nachajski M; Haeusler O; Iwanczyk M
    Pharmazie; 2004 Aug; 59(8):651-3. PubMed ID: 15378860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation and process development of (recombinant human) deoxyribonuclease I as a powder for inhalation.
    Zijlstra GS; Ponsioen BJ; Hummel SA; Sanders N; Hinrichs WL; de Boer AH; Frijlink HW
    Pharm Dev Technol; 2009; 14(4):358-68. PubMed ID: 19552563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alginate microspheres prepared by internal gelation: development and effect on insulin stability.
    Silva CM; Ribeiro AJ; Figueiredo IV; Gonçalves AR; Veiga F
    Int J Pharm; 2006 Mar; 311(1-2):1-10. PubMed ID: 16442757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New formulation of recombinant coagulation factor: simplicity, rapidity and manageability].
    Fabregas B
    Soins; 2008 May; (725):22-3. PubMed ID: 18630084
    [No Abstract]   [Full Text] [Related]  

  • 17. Stability indicating validated HPLC method for quantification of levothyroxine with eight degradation peaks in the presence of excipients.
    Shah RB; Bryant A; Collier J; Habib MJ; Khan MA
    Int J Pharm; 2008 Aug; 360(1-2):77-82. PubMed ID: 18524511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Commercial challenges of protein drug delivery.
    Brown LR
    Expert Opin Drug Deliv; 2005 Jan; 2(1):29-42. PubMed ID: 16296733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scanning probe microscopy in the field of drug delivery.
    Turner YT; Roberts CJ; Davies MC
    Adv Drug Deliv Rev; 2007 Dec; 59(14):1453-73. PubMed ID: 17920719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation and stability testing of photolabile drugs.
    Tønnesen HH
    Int J Pharm; 2001 Aug; 225(1-2):1-14. PubMed ID: 11489550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.